Atrial flutter is a type of abnormal heart rhythm, also known as an arrhythmia, that affects the atria. In atrial flutter, the electrical signals that control the heart’s rhythm become abnormal, causing the atria to beat rapidly and in a coordinated manner. This rapid and regular beating can result in a fast heart rate.
The symptoms of atrial flutter can vary from person to person. Some individuals may experience no symptoms, while others may experience palpitations (rapid or irregular heartbeat), chest discomfort, shortness of breath, fatigue, lightheadedness, or fainting. If left untreated, atrial flutter can lead to complications.
The rapid heart rate associated with atrial flutter can reduce the heart’s efficiency and increase the risk of blood clots forming in the atria. These blood clots can travel to other parts of the body, causing a stroke or other problems.
Epidemiology
Atrial flutter is less common than atrial fibrillation (AF), another type of arrhythmia. However, atrial flutter often coexists with AF, and the two conditions share some similarities in terms of risk factors and management. The incidence of atrial flutter increases with age, with most cases occurring in individuals over 60.
It is less common in younger individuals but can still occur, particularly in those with structural heart disease or certain risk factors. Atrial flutter has been observed to affect men more frequently than women.
However, in certain subgroups, such as younger individuals or those with structural heart disease, the gender difference may not be as pronounced. Atrial flutter can be a recurrent condition, with some individuals experiencing multiple episodes over time. The frequency and pattern of recurrence can vary among individuals.
Anatomy
Pathophysiology
Atrial flutter typically occurs due to the formation of a re-entry circuit within the atria. This circuit consists of a loop of abnormal electrical pathways that allows electrical signals to circulate in a rapid, repetitive manner. The re-entry circuit in atrial flutter is usually a large, organized circuit involving both atria.
It often forms around anatomical or functional barriers within the atrial tissue, such as scar tissue from prior heart surgeries or underlying structural heart disease. This circuit allows the electrical impulses to circulate continuously in a circular pattern. Unlike atrial fibrillation, characterized by chaotic and irregular electrical signals, atrial flutter exhibits a more regular pattern.
The electrical impulses circulate within the re-entry circuit at a constant rate, resulting in a characteristic “sawtooth” pattern on the electrocardiogram. The AV node, which serves as a gatekeeper between the atria and the ventricles, can partially block the rapid atrial impulses from reaching the ventricles. This results in a slower ventricular rate, which is typically around 150 bpm in atrial flutter but can vary depending on individual factors.
The fast and regular atrial rhythm in atrial flutter can have several hemodynamic effects. The atria may contract more forcefully and less effectively due to the rapid rate, potentially compromising their ability to fill the ventricles adequately. As a result, cardiac output may be reduced, leading to symptoms such as palpitations, shortness of breath, and fatigue.
Etiology
Structural heart disease: Structural abnormalities or diseases affecting the heart, such as coronary artery disease, valvular heart disease (e.g., mitral valve disease), or congenital heart defects (e.g., atrial septal defects), can increase the risk of developing atrial flutter. These conditions can create the anatomical substrate that facilitates the formation of re-entry circuits.
Cardiac surgery: Atrial flutter can occur as a complication of cardiac surgery, particularly procedures that involve manipulation or incisions in the atrial tissue. The presence of scar tissue resulting from surgery can create the necessary substrate for re-entry circuits to form.
Hypertension: High blood pressure is a known risk factor for atrial flutter. The elevated pressure within the heart chambers and blood vessels can cause electrical and structural changes in the atria, increasing the likelihood of abnormal electrical pathways and re-entry circuits.
Hyperthyroidism: Overactive thyroid function has been associated with an increased risk of atrial flutter. The excess thyroid hormones can affect the electrical properties of the heart, leading to arrhythmias.
Chronic lung disease: Conditions such as chronic obstructive pulmonary disease (COPD) or pulmonary hypertension can contribute to the development of atrial flutter. The changes in lung function and increased pressure within the pulmonary circulation can impact the heart’s electrical activity.
Alcohol and drug abuse: Excessive alcohol consumption and certain drug use (e.g., cocaine) have been linked to an increased risk of atrial flutter. These substances can directly affect the electrical conduction system of the heart or contribute to underlying heart disease.
Electrolyte imbalances: Abnormal levels of electrolytes, such as potassium, magnesium, or calcium, can disrupt the normal electrical signaling in the heart and increase the susceptibility to arrhythmias, including atrial flutter.
Other factors that may contribute to atrial flutter include age (the risk increases with advancing age), obesity, diabetes, sleep apnea, and certain medications (e.g., some antiarrhythmic drugs).
Genetics
Prognostic Factors
The prognosis for patients with typical atrial flutter who undergo catheter ablation is generally favorable, with a low recurrence rate of less than 5%. However, if atrial flutter persists and goes untreated, it can lead to a condition known as tachycardia-induced cardiomyopathy, which is challenging to manage and often results in repeated hospitalizations due to heart failure decompensation.
Clinical History
Clinical History
The patient’s reported symptoms are essential in evaluating atrial flutter. Common symptoms may include palpitations, chest discomfort or pain, shortness of breath, fatigue, lightheadedness, dizziness, fainting, or a feeling of a fluttering sensation in the chest. It is important to determine when the symptoms first started and the duration of each episode of atrial flutter. Identifying any triggers or factors that worsen or provoke atrial flutter episodes can be helpful.
This may include physical exertion, emotional stress, certain medications or substances (e.g., alcohol, stimulants), or other specific situations. Medical history of cardiovascular diseases (e.g., hypertension, coronary artery disease), structural heart defects, heart surgeries, heart valve disorders, lung diseases, thyroid disorders, diabetes, or any other significant medical conditions should be noted. Lifestyle factors, such as smoking, alcohol consumption, and recreational drug use, should be assessed as they can impact cardiac health and the occurrence of arrhythmias.
Information regarding any previous diagnostic tests, such as ECGs, echocardiograms, stress tests, or Holter monitoring, should be reviewed. These tests help confirm the diagnosis of atrial flutter and evaluate its impact on cardiac function. Inquiring about a family history of cardiac arrhythmias or other cardiovascular conditions may provide valuable insights into potential genetic or hereditary factors contributing to atrial flutter.
Physical Examination
Physical Examination
Atrial flutter is often characterized by a rapid and regular atrial rhythm but an irregular ventricular response. As a result, an irregular pulse may be palpated during the examination. A examiner may detect abnormal heart sounds upon auscultation. These may include a rapid or irregular heartbeat and an irregularly irregular rhythm. In some cases, there may be a discrepancy between the heart rate heard on auscultation and the pulse rate felt at the peripheral pulse points.
This difference, known as a pulse deficit, occurs because not all atrial impulses are conducted to the ventricles, resulting in missed ventricular contractions. Fluid overload and congestion may be observed if atrial flutter has caused or contributed to heart failure. These include elevated jugular venous pressure, pulmonary crackles (rales) on lung auscultation, peripheral edema, and hepatomegaly. Atrial flutter itself may not cause significant changes in blood pressure.
However, underlying cardiovascular conditions or comorbidities can contribute to blood pressure abnormalities, which may be identified during the physical examination. Depending on the individual and associated factors, additional findings may be present. These can include signs of underlying structural heart disease (e.g., murmurs, abnormal heart sounds), signs of hyperthyroidism (e.g., rapid heartbeat, tremor, warm skin), or signs related to complications such as embolic phenomena (e.g., focal neurological deficits).
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Differential Diagnoses
Atrial Tachycardia
Atrial Fibrillation
Multifocal Atrial Tachycardia
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Rhythm Control
The primary goal in managing atrial flutter is to achieve and maintain sinus rhythm or convert the arrhythmia back to sinus rhythm. If atrial flutter persists, it can lead to chronic remodeling of the atrial tissue, making rate control and rhythm conversion more challenging. Various methods can be used to restore sinus rhythm, including electrical cardioversion, pharmacological cardioversion, and ultimately, catheter ablation.
The management of atrial flutter is divided into acute and long-term strategies. In stable patients, pharmacological cardioversion using different antiarrhythmic drugs can be attempted. However, despite the availability of multiple pharmacological options, achieving control and conversion of atrial flutter to sinus rhythm can be difficult.
In cases of newly diagnosed atrial flutter, anticoagulation therapy should be initiated to reduce the risk of blood clots. If there is no evidence of intracardiac thrombus, electrical cardioversion may be considered, especially in stable patients, to prevent the persistence of the arrhythmia and the development of further fibrosis, which can perpetuate atrial flutter and make it more difficult to control or convert to sinus rhythm.
Rate Control
Rate control in atrial flutter can be achieved using atrioventricular (AV) nodal agents, such as calcium channel blockers (preferred as first-line therapy) or beta blockers. However, digoxin should be cautiously used due to its potential side effects and toxicity. Combining these medications can be considered for optimal rate control.
It is important to note that achieving adequate rate control in atrial flutter can be challenging since the arrhythmia continuously fires at the same rate towards the AV node. The target heart rate for rate control in atrial flutter is typically set below 110 beats per minute. The RACE II trial (Rate Control
Efficacy in Permanent Atrial Fibrillation: A Comparison between Lenient versus Strict Rate Control II) helped establish this heart rate goal. Although the study focused on patients with atrial fibrillation, the findings can be extrapolated to rate control in atrial flutter. The trial compared strict heart rate control (<80 bpm) with lenient heart rate control (<110 bpm) and concluded that very stringent heart rate control is not necessary.
Lenient rate control resulted in fewer side effects, reduced polypharmacy, and fewer outpatient visits. In cases where patients are intolerant to medications or have significant bradycardia due to rate control measures, catheter ablation is an alternative option.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
Media Gallary
References
News
Vaping’s ‘95% Safer’ Claim Debated for Youth Health
Posted on
News
Google DeepMind’s AI Revolutionizes the Search for Disease Genes
Posted on
News
Mosquitoes Pose New Challenge to Public Health
Posted on
News
3D-Printed e3-skin Redefines Wearable Health Monitoring
Atrial flutter is a type of abnormal heart rhythm, also known as an arrhythmia, that affects the atria. In atrial flutter, the electrical signals that control the heart’s rhythm become abnormal, causing the atria to beat rapidly and in a coordinated manner. This rapid and regular beating can result in a fast heart rate.
The symptoms of atrial flutter can vary from person to person. Some individuals may experience no symptoms, while others may experience palpitations (rapid or irregular heartbeat), chest discomfort, shortness of breath, fatigue, lightheadedness, or fainting. If left untreated, atrial flutter can lead to complications.
The rapid heart rate associated with atrial flutter can reduce the heart’s efficiency and increase the risk of blood clots forming in the atria. These blood clots can travel to other parts of the body, causing a stroke or other problems.
Atrial flutter is less common than atrial fibrillation (AF), another type of arrhythmia. However, atrial flutter often coexists with AF, and the two conditions share some similarities in terms of risk factors and management. The incidence of atrial flutter increases with age, with most cases occurring in individuals over 60.
It is less common in younger individuals but can still occur, particularly in those with structural heart disease or certain risk factors. Atrial flutter has been observed to affect men more frequently than women.
However, in certain subgroups, such as younger individuals or those with structural heart disease, the gender difference may not be as pronounced. Atrial flutter can be a recurrent condition, with some individuals experiencing multiple episodes over time. The frequency and pattern of recurrence can vary among individuals.
Atrial flutter typically occurs due to the formation of a re-entry circuit within the atria. This circuit consists of a loop of abnormal electrical pathways that allows electrical signals to circulate in a rapid, repetitive manner. The re-entry circuit in atrial flutter is usually a large, organized circuit involving both atria.
It often forms around anatomical or functional barriers within the atrial tissue, such as scar tissue from prior heart surgeries or underlying structural heart disease. This circuit allows the electrical impulses to circulate continuously in a circular pattern. Unlike atrial fibrillation, characterized by chaotic and irregular electrical signals, atrial flutter exhibits a more regular pattern.
The electrical impulses circulate within the re-entry circuit at a constant rate, resulting in a characteristic “sawtooth” pattern on the electrocardiogram. The AV node, which serves as a gatekeeper between the atria and the ventricles, can partially block the rapid atrial impulses from reaching the ventricles. This results in a slower ventricular rate, which is typically around 150 bpm in atrial flutter but can vary depending on individual factors.
The fast and regular atrial rhythm in atrial flutter can have several hemodynamic effects. The atria may contract more forcefully and less effectively due to the rapid rate, potentially compromising their ability to fill the ventricles adequately. As a result, cardiac output may be reduced, leading to symptoms such as palpitations, shortness of breath, and fatigue.
Structural heart disease: Structural abnormalities or diseases affecting the heart, such as coronary artery disease, valvular heart disease (e.g., mitral valve disease), or congenital heart defects (e.g., atrial septal defects), can increase the risk of developing atrial flutter. These conditions can create the anatomical substrate that facilitates the formation of re-entry circuits.
Cardiac surgery: Atrial flutter can occur as a complication of cardiac surgery, particularly procedures that involve manipulation or incisions in the atrial tissue. The presence of scar tissue resulting from surgery can create the necessary substrate for re-entry circuits to form.
Hypertension: High blood pressure is a known risk factor for atrial flutter. The elevated pressure within the heart chambers and blood vessels can cause electrical and structural changes in the atria, increasing the likelihood of abnormal electrical pathways and re-entry circuits.
Hyperthyroidism: Overactive thyroid function has been associated with an increased risk of atrial flutter. The excess thyroid hormones can affect the electrical properties of the heart, leading to arrhythmias.
Chronic lung disease: Conditions such as chronic obstructive pulmonary disease (COPD) or pulmonary hypertension can contribute to the development of atrial flutter. The changes in lung function and increased pressure within the pulmonary circulation can impact the heart’s electrical activity.
Alcohol and drug abuse: Excessive alcohol consumption and certain drug use (e.g., cocaine) have been linked to an increased risk of atrial flutter. These substances can directly affect the electrical conduction system of the heart or contribute to underlying heart disease.
Electrolyte imbalances: Abnormal levels of electrolytes, such as potassium, magnesium, or calcium, can disrupt the normal electrical signaling in the heart and increase the susceptibility to arrhythmias, including atrial flutter.
Other factors that may contribute to atrial flutter include age (the risk increases with advancing age), obesity, diabetes, sleep apnea, and certain medications (e.g., some antiarrhythmic drugs).
The prognosis for patients with typical atrial flutter who undergo catheter ablation is generally favorable, with a low recurrence rate of less than 5%. However, if atrial flutter persists and goes untreated, it can lead to a condition known as tachycardia-induced cardiomyopathy, which is challenging to manage and often results in repeated hospitalizations due to heart failure decompensation.
Clinical History
The patient’s reported symptoms are essential in evaluating atrial flutter. Common symptoms may include palpitations, chest discomfort or pain, shortness of breath, fatigue, lightheadedness, dizziness, fainting, or a feeling of a fluttering sensation in the chest. It is important to determine when the symptoms first started and the duration of each episode of atrial flutter. Identifying any triggers or factors that worsen or provoke atrial flutter episodes can be helpful.
This may include physical exertion, emotional stress, certain medications or substances (e.g., alcohol, stimulants), or other specific situations. Medical history of cardiovascular diseases (e.g., hypertension, coronary artery disease), structural heart defects, heart surgeries, heart valve disorders, lung diseases, thyroid disorders, diabetes, or any other significant medical conditions should be noted. Lifestyle factors, such as smoking, alcohol consumption, and recreational drug use, should be assessed as they can impact cardiac health and the occurrence of arrhythmias.
Information regarding any previous diagnostic tests, such as ECGs, echocardiograms, stress tests, or Holter monitoring, should be reviewed. These tests help confirm the diagnosis of atrial flutter and evaluate its impact on cardiac function. Inquiring about a family history of cardiac arrhythmias or other cardiovascular conditions may provide valuable insights into potential genetic or hereditary factors contributing to atrial flutter.
Physical Examination
Atrial flutter is often characterized by a rapid and regular atrial rhythm but an irregular ventricular response. As a result, an irregular pulse may be palpated during the examination. A examiner may detect abnormal heart sounds upon auscultation. These may include a rapid or irregular heartbeat and an irregularly irregular rhythm. In some cases, there may be a discrepancy between the heart rate heard on auscultation and the pulse rate felt at the peripheral pulse points.
This difference, known as a pulse deficit, occurs because not all atrial impulses are conducted to the ventricles, resulting in missed ventricular contractions. Fluid overload and congestion may be observed if atrial flutter has caused or contributed to heart failure. These include elevated jugular venous pressure, pulmonary crackles (rales) on lung auscultation, peripheral edema, and hepatomegaly. Atrial flutter itself may not cause significant changes in blood pressure.
However, underlying cardiovascular conditions or comorbidities can contribute to blood pressure abnormalities, which may be identified during the physical examination. Depending on the individual and associated factors, additional findings may be present. These can include signs of underlying structural heart disease (e.g., murmurs, abnormal heart sounds), signs of hyperthyroidism (e.g., rapid heartbeat, tremor, warm skin), or signs related to complications such as embolic phenomena (e.g., focal neurological deficits).
Differential Diagnoses
Atrial Tachycardia
Atrial Fibrillation
Multifocal Atrial Tachycardia
Rhythm Control
The primary goal in managing atrial flutter is to achieve and maintain sinus rhythm or convert the arrhythmia back to sinus rhythm. If atrial flutter persists, it can lead to chronic remodeling of the atrial tissue, making rate control and rhythm conversion more challenging. Various methods can be used to restore sinus rhythm, including electrical cardioversion, pharmacological cardioversion, and ultimately, catheter ablation.
The management of atrial flutter is divided into acute and long-term strategies. In stable patients, pharmacological cardioversion using different antiarrhythmic drugs can be attempted. However, despite the availability of multiple pharmacological options, achieving control and conversion of atrial flutter to sinus rhythm can be difficult.
In cases of newly diagnosed atrial flutter, anticoagulation therapy should be initiated to reduce the risk of blood clots. If there is no evidence of intracardiac thrombus, electrical cardioversion may be considered, especially in stable patients, to prevent the persistence of the arrhythmia and the development of further fibrosis, which can perpetuate atrial flutter and make it more difficult to control or convert to sinus rhythm.
Rate Control
Rate control in atrial flutter can be achieved using atrioventricular (AV) nodal agents, such as calcium channel blockers (preferred as first-line therapy) or beta blockers. However, digoxin should be cautiously used due to its potential side effects and toxicity. Combining these medications can be considered for optimal rate control.
It is important to note that achieving adequate rate control in atrial flutter can be challenging since the arrhythmia continuously fires at the same rate towards the AV node. The target heart rate for rate control in atrial flutter is typically set below 110 beats per minute. The RACE II trial (Rate Control
Efficacy in Permanent Atrial Fibrillation: A Comparison between Lenient versus Strict Rate Control II) helped establish this heart rate goal. Although the study focused on patients with atrial fibrillation, the findings can be extrapolated to rate control in atrial flutter. The trial compared strict heart rate control (<80 bpm) with lenient heart rate control (<110 bpm) and concluded that very stringent heart rate control is not necessary.
Lenient rate control resulted in fewer side effects, reduced polypharmacy, and fewer outpatient visits. In cases where patients are intolerant to medications or have significant bradycardia due to rate control measures, catheter ablation is an alternative option.
medtigo
Atrial Flutter
Updated :
August 30, 2023
Atrial flutter is a type of abnormal heart rhythm, also known as an arrhythmia, that affects the atria. In atrial flutter, the electrical signals that control the heart’s rhythm become abnormal, causing the atria to beat rapidly and in a coordinated manner. This rapid and regular beating can result in a fast heart rate.
The symptoms of atrial flutter can vary from person to person. Some individuals may experience no symptoms, while others may experience palpitations (rapid or irregular heartbeat), chest discomfort, shortness of breath, fatigue, lightheadedness, or fainting. If left untreated, atrial flutter can lead to complications.
The rapid heart rate associated with atrial flutter can reduce the heart’s efficiency and increase the risk of blood clots forming in the atria. These blood clots can travel to other parts of the body, causing a stroke or other problems.
Atrial flutter is less common than atrial fibrillation (AF), another type of arrhythmia. However, atrial flutter often coexists with AF, and the two conditions share some similarities in terms of risk factors and management. The incidence of atrial flutter increases with age, with most cases occurring in individuals over 60.
It is less common in younger individuals but can still occur, particularly in those with structural heart disease or certain risk factors. Atrial flutter has been observed to affect men more frequently than women.
However, in certain subgroups, such as younger individuals or those with structural heart disease, the gender difference may not be as pronounced. Atrial flutter can be a recurrent condition, with some individuals experiencing multiple episodes over time. The frequency and pattern of recurrence can vary among individuals.
Atrial flutter typically occurs due to the formation of a re-entry circuit within the atria. This circuit consists of a loop of abnormal electrical pathways that allows electrical signals to circulate in a rapid, repetitive manner. The re-entry circuit in atrial flutter is usually a large, organized circuit involving both atria.
It often forms around anatomical or functional barriers within the atrial tissue, such as scar tissue from prior heart surgeries or underlying structural heart disease. This circuit allows the electrical impulses to circulate continuously in a circular pattern. Unlike atrial fibrillation, characterized by chaotic and irregular electrical signals, atrial flutter exhibits a more regular pattern.
The electrical impulses circulate within the re-entry circuit at a constant rate, resulting in a characteristic “sawtooth” pattern on the electrocardiogram. The AV node, which serves as a gatekeeper between the atria and the ventricles, can partially block the rapid atrial impulses from reaching the ventricles. This results in a slower ventricular rate, which is typically around 150 bpm in atrial flutter but can vary depending on individual factors.
The fast and regular atrial rhythm in atrial flutter can have several hemodynamic effects. The atria may contract more forcefully and less effectively due to the rapid rate, potentially compromising their ability to fill the ventricles adequately. As a result, cardiac output may be reduced, leading to symptoms such as palpitations, shortness of breath, and fatigue.
Structural heart disease: Structural abnormalities or diseases affecting the heart, such as coronary artery disease, valvular heart disease (e.g., mitral valve disease), or congenital heart defects (e.g., atrial septal defects), can increase the risk of developing atrial flutter. These conditions can create the anatomical substrate that facilitates the formation of re-entry circuits.
Cardiac surgery: Atrial flutter can occur as a complication of cardiac surgery, particularly procedures that involve manipulation or incisions in the atrial tissue. The presence of scar tissue resulting from surgery can create the necessary substrate for re-entry circuits to form.
Hypertension: High blood pressure is a known risk factor for atrial flutter. The elevated pressure within the heart chambers and blood vessels can cause electrical and structural changes in the atria, increasing the likelihood of abnormal electrical pathways and re-entry circuits.
Hyperthyroidism: Overactive thyroid function has been associated with an increased risk of atrial flutter. The excess thyroid hormones can affect the electrical properties of the heart, leading to arrhythmias.
Chronic lung disease: Conditions such as chronic obstructive pulmonary disease (COPD) or pulmonary hypertension can contribute to the development of atrial flutter. The changes in lung function and increased pressure within the pulmonary circulation can impact the heart’s electrical activity.
Alcohol and drug abuse: Excessive alcohol consumption and certain drug use (e.g., cocaine) have been linked to an increased risk of atrial flutter. These substances can directly affect the electrical conduction system of the heart or contribute to underlying heart disease.
Electrolyte imbalances: Abnormal levels of electrolytes, such as potassium, magnesium, or calcium, can disrupt the normal electrical signaling in the heart and increase the susceptibility to arrhythmias, including atrial flutter.
Other factors that may contribute to atrial flutter include age (the risk increases with advancing age), obesity, diabetes, sleep apnea, and certain medications (e.g., some antiarrhythmic drugs).
The prognosis for patients with typical atrial flutter who undergo catheter ablation is generally favorable, with a low recurrence rate of less than 5%. However, if atrial flutter persists and goes untreated, it can lead to a condition known as tachycardia-induced cardiomyopathy, which is challenging to manage and often results in repeated hospitalizations due to heart failure decompensation.
Clinical History
The patient’s reported symptoms are essential in evaluating atrial flutter. Common symptoms may include palpitations, chest discomfort or pain, shortness of breath, fatigue, lightheadedness, dizziness, fainting, or a feeling of a fluttering sensation in the chest. It is important to determine when the symptoms first started and the duration of each episode of atrial flutter. Identifying any triggers or factors that worsen or provoke atrial flutter episodes can be helpful.
This may include physical exertion, emotional stress, certain medications or substances (e.g., alcohol, stimulants), or other specific situations. Medical history of cardiovascular diseases (e.g., hypertension, coronary artery disease), structural heart defects, heart surgeries, heart valve disorders, lung diseases, thyroid disorders, diabetes, or any other significant medical conditions should be noted. Lifestyle factors, such as smoking, alcohol consumption, and recreational drug use, should be assessed as they can impact cardiac health and the occurrence of arrhythmias.
Information regarding any previous diagnostic tests, such as ECGs, echocardiograms, stress tests, or Holter monitoring, should be reviewed. These tests help confirm the diagnosis of atrial flutter and evaluate its impact on cardiac function. Inquiring about a family history of cardiac arrhythmias or other cardiovascular conditions may provide valuable insights into potential genetic or hereditary factors contributing to atrial flutter.
Physical Examination
Atrial flutter is often characterized by a rapid and regular atrial rhythm but an irregular ventricular response. As a result, an irregular pulse may be palpated during the examination. A examiner may detect abnormal heart sounds upon auscultation. These may include a rapid or irregular heartbeat and an irregularly irregular rhythm. In some cases, there may be a discrepancy between the heart rate heard on auscultation and the pulse rate felt at the peripheral pulse points.
This difference, known as a pulse deficit, occurs because not all atrial impulses are conducted to the ventricles, resulting in missed ventricular contractions. Fluid overload and congestion may be observed if atrial flutter has caused or contributed to heart failure. These include elevated jugular venous pressure, pulmonary crackles (rales) on lung auscultation, peripheral edema, and hepatomegaly. Atrial flutter itself may not cause significant changes in blood pressure.
However, underlying cardiovascular conditions or comorbidities can contribute to blood pressure abnormalities, which may be identified during the physical examination. Depending on the individual and associated factors, additional findings may be present. These can include signs of underlying structural heart disease (e.g., murmurs, abnormal heart sounds), signs of hyperthyroidism (e.g., rapid heartbeat, tremor, warm skin), or signs related to complications such as embolic phenomena (e.g., focal neurological deficits).
Differential Diagnoses
Atrial Tachycardia
Atrial Fibrillation
Multifocal Atrial Tachycardia
Rhythm Control
The primary goal in managing atrial flutter is to achieve and maintain sinus rhythm or convert the arrhythmia back to sinus rhythm. If atrial flutter persists, it can lead to chronic remodeling of the atrial tissue, making rate control and rhythm conversion more challenging. Various methods can be used to restore sinus rhythm, including electrical cardioversion, pharmacological cardioversion, and ultimately, catheter ablation.
The management of atrial flutter is divided into acute and long-term strategies. In stable patients, pharmacological cardioversion using different antiarrhythmic drugs can be attempted. However, despite the availability of multiple pharmacological options, achieving control and conversion of atrial flutter to sinus rhythm can be difficult.
In cases of newly diagnosed atrial flutter, anticoagulation therapy should be initiated to reduce the risk of blood clots. If there is no evidence of intracardiac thrombus, electrical cardioversion may be considered, especially in stable patients, to prevent the persistence of the arrhythmia and the development of further fibrosis, which can perpetuate atrial flutter and make it more difficult to control or convert to sinus rhythm.
Rate Control
Rate control in atrial flutter can be achieved using atrioventricular (AV) nodal agents, such as calcium channel blockers (preferred as first-line therapy) or beta blockers. However, digoxin should be cautiously used due to its potential side effects and toxicity. Combining these medications can be considered for optimal rate control.
It is important to note that achieving adequate rate control in atrial flutter can be challenging since the arrhythmia continuously fires at the same rate towards the AV node. The target heart rate for rate control in atrial flutter is typically set below 110 beats per minute. The RACE II trial (Rate Control
Efficacy in Permanent Atrial Fibrillation: A Comparison between Lenient versus Strict Rate Control II) helped establish this heart rate goal. Although the study focused on patients with atrial fibrillation, the findings can be extrapolated to rate control in atrial flutter. The trial compared strict heart rate control (<80 bpm) with lenient heart rate control (<110 bpm) and concluded that very stringent heart rate control is not necessary.
Lenient rate control resulted in fewer side effects, reduced polypharmacy, and fewer outpatient visits. In cases where patients are intolerant to medications or have significant bradycardia due to rate control measures, catheter ablation is an alternative option.
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
